| Autor: |
Xu, Ke‐dong1 (AUTHOR), Miao, Yi2 (AUTHOR), Li, Pan2 (AUTHOR), Li, Ping‐ping2 (AUTHOR), Liu, Jie2 (AUTHOR), Li, Juan2 (AUTHOR), Cao, Fang2 (AUTHOR) lanching@xjtu.edu.cn |
| Předmět: |
|
| Zdroj: |
Environmental Toxicology. Mar2022, Vol. 37 Issue 3, p564-573. 10p. |
| Abstrakt: |
Overexpression or activation of Yes‐associated protein (YAP) is common in cancer cells. Thus, targeting YAP may be a strategy for cancer therapy. Licochalcone A (LicA) is a primary active compound of licorice root and is known to have medicinal effects, such as antioxidant, antibacterial, antiviral, and anticancer effects. However, the anticancer pharmacological mechanism of LicA has not been investigated in cholangiocarcinoma. In this study, we investigated the antiproliferative effect of LicA and the underlying molecular mechanism in HCCC‐9810 and RBE human cholangiocarcinoma cells. Our experiments indicated that LicA suppressed the growth of cholangiocarcinoma cells through inactivation of the Hippo pathway. Pescadillo ribosomal biogenesis factor 1 (PES1) was notably upregulated and related to carcinogenesis. We also found that LicA suppressed the expression and nuclear localization of PES1, which was associated with the inhibition of YAP expression and transcriptional activity. [ABSTRACT FROM AUTHOR] |
| Databáze: |
GreenFILE |
| Externí odkaz: |
|
Plný text